36 resources
| Package | Identity | Name/Title | Status | Date | Resource |
|---|---|---|---|---|---|
| hl7.fhir.efss | MyPatient  | MyPatient | draft | 2024-04 | Patient |
| hl7.fhir.us.pq-cmc-fda | ContainerClosure | ContainerClosure | active | 2024-08 | PackagedProductDefinition |
| hl7.fhir.us.pq-cmc-fda | cmc-document-reference | Document Reference Attachment | active | 2024-08 | DocumentReference |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32p10 | CMC eCTD 32P10 Document | active | 2024-08 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32p32 | CMC eCTD 32P32 Document | active | 2024-08 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32p55 | CMC eCTD 32P55 Document | active | 2024-08 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32s10 | CMC eCTD 32S10 Document | active | 2024-08 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32s23 | CMC eCTD 32S23 Document | active | 2024-08 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32s3 | CMC eCTD 32S3 Document | active | 2024-08 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-sp4151 | CMC eCTD SP4151 Document | active | 2024-08 | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-organization | Basic Organization | active | 2024-08 | Organization |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32p10 | eCTD Product Description and Composition | active | 2024-08 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32p32 | eCTD Batch Formula | active | 2024-08 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32p55 | eCTD Product Characterisation of Impurities Composition | active | 2024-08 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32s10 | eCTD Substance General Information | active | 2024-08 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32s23 | eCTD Substance Control of Materials Composition | active | 2024-08 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32s3 | eCTD Substance Characterisation | active | 2024-08 | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-sp4151 | eCTD Specification Composition | active | 2024-08 | Composition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-batch-formula-product | Batch Formula Drug Product Identification | active | 2024-08 | MedicinalProductDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-component-substance | Component Substance | active | 2024-08 | SubstanceDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-component | Drug Product Component | active | 2024-08 | Ingredient |
| hl7.fhir.us.pq-cmc-fda | pqcmc-dp-ingredient | Drug Product Batch Formula Ingredient | active | 2024-08 | Ingredient |
| hl7.fhir.us.pq-cmc-fda | pqcmc-drug-product-description | Drug Product Description | active | 2024-08 | MedicinalProductDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-drug-product-handle | Drug Product Handle | active | 2024-08 | MedicinalProductDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-drug-product-substance-impurity | Drug Substance Impurity | active | 2024-08 | SubstanceDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-drug-product-with-impurities | Drug Product Impurities | active | 2024-08 | MedicinalProductDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-drug-substance-characterisation | Drug Substance | active | 2024-08 | SubstanceDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-drug-substance-nomenclature-structure | Substance General Information | active | 2024-08 | SubstanceDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-excipient | Excipient Drug Substance | active | 2024-08 | SubstanceDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-graphic-reference | Graphic Reference | active | 2024-08 | DocumentReference |
| hl7.fhir.us.pq-cmc-fda | pqcmc-polymorphic-form | Polymorphic Form | active | 2024-08 | SubstanceDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-product-batch-formula | Drug Product Batch Formula | active | 2024-08 | ManufacturedItemDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-product-part | Manufactured Drug Product | active | 2024-08 | ManufacturedItemDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-quality-specification | Quality Specification | active | 2024-08 | PlanDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-routine-drug-substance | Drug Substance Handle | active | 2024-08 | SubstanceDefinition |
| hl7.fhir.us.pq-cmc-fda | pqcmc-structure-reference | Structure Data Reference | active | 2024-08 | DocumentReference |
XIG built as of 08 Sep 2024. Found 38544 resources in 659 packages.
FHIR